- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- ROUNDTABLE: Pharmacy’s future in sync with technology
- CVS Caremark to stop selling tobacco in all store locations
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Organix-South develops new Purifying Neem Facial Mask
LOS ANGELES —Following years of research and 10 new technology patents, skin care brand Neutrogena has introduced its new Neutrogena Clinical.
To develop Neutrogena Clinical, scientists at the company looked to bioelectricity, the body’s innate electrical signaling system. Neutrogena scientists discovered a way to create tiny, ion-mineral conductors within a topical formulation that, once activated, work like “miniaturized batteries” to simulate bioelectricity and increase positive ion flow. This helps minimize visible signs of collagen loss, improve facial definition and reduce the appearance of wrinkles and sagging skin.
The collection, which hit stores the first week of March, includes facial lifting wrinkle treatment SPF 30 ($39.99); eye lift contouring treatment ($39.99); lifting wrinkle treatment starter system—SPF 30 and eye ($49.99); and facial lifting wrinkle treatment night ($39.99).